playing the BIG boards. options included. making the profits with this volitality !
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
glad you got the message and we see things similar.
OWCP,..long and strong !
and that assessment of why OWCP's pps is where it is at would be incorrect.
in order for a market to be created company shares (OWCP) have to be in abundance for market makers to create buy and sell transactions.
i say in abundance because like what occurred with Tilray. they had to suspend trading because the mm's were caught with more orders than they could fill.
the exact same phenomena can occur with OWCP.
i submit that not only are mm's collecting shares for the anticipated run in pps for OWCP but this is also giving institutions buying opportunity at these insane low prices.
OWCP ,..long and strong
i stand corrected ;)
SPRINGERGULCH,...sounds like a very conservative estimate. but a BILLION is a fantastic starting place.
OWCP is the real deal.
OWCP has the goods.
OWCP has patents already in place.
OWCP will collect on any company royalties or licensing fees for any infringement on their patents.
OWCP will most likely be a dominant force in CBD based products.
To bring a high quality cannabis-based product to market takes major R&D.
OWCP has conducted that R&D and is now getting patents in receivership mode. that is why they brought on all these top level doctors and scientists. if when interviewing these top level individuals in their field at any time an inconsistency appeared these top level doctors and scientists would not be on OWCP board.
important point is being made here.
these individuals now are in alignment with the work OWCP has and have in fact added to it. multiple patents were brought from one doctor in particular,...now it is a team OWCP.
there are many CBD based products out on the market. many are misleading. here's an example of 2 products costing the same ($45 per 1/2oz bottle);
a product can boast 1500mg of CBD. but the snag here is it takes 5-20 drops of that particular product to have any affect on the person ingesting it.
another product will have 260mg of CBD. on the surface that appears that the other product with 1500mg is the better product,..1500mg vs. 260mg. but,..it only takes 1 drop of the 260mg to achieve the same affect the 1500mg has. that is 10 times the amount of CBD oil. the 1500mg product will be gone and the 260mg can be used of months.
for the potential OWCP customer it is important to undersatand that the extraction method is paramount to creating a superior OWCP cannabis-based product. i assisted in the creation of a particular CBD product and i know the research it took, i know whether to use isolate or raw,...i know the extraction methods that preserve the important other CBD components adding to high quality product,...i know what transport oil is best for a high quality CBD based product. if hemp is used you can be rest assured that the company offering that is not a true CBD product company. those companies are just getting on the bandwagon trend in CBD's.
OWCP has not done that. they have stayed true to their science and are delivering a high quality cannabis-based product(s).
OWCP is the real deal.
OWCP has the goods.
OWCP has patents already in place.
OWCP will collect on any company royalties or licensing fees for any infringement on their patents.
OWCP will most likely be a dominant force in CBD based products.
you are exactly correct !!!! maybe OWCP will follow Tilray's parabolic jump in pps,...
THE SHIFT IS ABOUT TO HIT THE FAN
$ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $
the factual reason,...cannabis vs hemp =====>
Cannabidiol expression is typically limited to flowering buds and not stalk, fiber, or sterilized seeds; this is true of all cannabis varieties. Traditional hemp is an inefficient source of CBD, requiring many acres to be cultivated to produce significant amounts of CBD extract. Moreover, hemp is considered a “bioaccumulator” or “phytoremediator.” It absorbs heavy metals and other chemical waste from the soil [12]. Accordingly, if large quantities of hemp are being cultivated to produce CBD, it is critically important that the quality of the soil is closely monitored and regulated.
The seeds of industrial hemp plants have important uses in human nutrition. They are a good source of protein, and the seed oil is rich in Omega-3 and Omega-6 fatty acids. The seed is used to make bread, cereals, and protein powder; the oil is used for margarine, salad dressing, cosmetics, and dietary supplements.
However, hemp seeds contain virtually no cannabinoids, which are in the flowers and (to a lesser extent) in the upper leaves [13]. Hemp seed oil is often used to dissolve the thick CBD extract (hence the term “CBD hemp oil”); however, as noted, olive oil, refined coconut oil, and other vehicles also can be used (hence the term “CBD oil”). In all cases, the CBD has been extracted from the flowering portion of the plant. If the entire plant is harvested, the CBD has been extracted from the total plant material, including the flowering portion.
the bottom line any oil olive oil, refined coconut oil, sea buckhorn oil, etc and other vehicles also can be used as a transport vehicle for high quality cannabis-based products.
if hemp is used it is only for a transport vehicle only and as noted,... hemp seeds contain virtually no cannabinoids.
some OWCP undisputedfacts ====>
OWCP has gone through the proper steps to prove their product is effective, safe, and flat out LEGIT. They’re finishing up studies in the largest hospital in Israel.
https://en.wikipedia.org/wiki/Sheba_Medical_Center
Yes, Israel — the Medical Marijuana Capital of the World. Did you watch the CNN special with Dr. Sanjay Gupta? (My link starts the video closer to the point where they talk about Israel.)
fantastic news !! OWCP,...the state of the art cannabis-based company that will soon be a household name.
OWCP doesn't use hemp. That's for industrial use. Cannabis is what OWCP uses for their state of the art propritory products.
Those are the facts.
least we OWCP shareholders forget,...read the message from our CEO ===>
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143803754
LAUNCH TIME,...With respect to our timeline going forward, key events till the end of this year include the following:
- Completion of the cannabis cream safety study – Q4 2018
- Initiation of the Oral Disintegrating Tablet safety study – Q4 2018
- Completion of the Nasal Spray animal safety, pharmaco-kinetics and pharmaco-dynamics studies – Q4 2018
THE SHIFT IS ABOUT TO HIT THE FAN
the OWCP iBox has a huge amount of information on OWCP and it's operations,...just click on Show Intro on the right side of your screen.
OWCP Forum iBox
https://investorshub.advfn.com/OWC-Pharmaceutical-Research-Corp-OWCP-16859/
moxa1,...that is a very important distinction. thank you for bringing clarity to that point and fact.
it's actually the extraction process that is paramount in any CBD product.
it ensures the high quality.
to conduct the proper extraction process,...the multiple CBD's (CBDa, etc) and surrounding substances become essential to any high quality cannabis-based product.
OWCP has the real goods.
THE SHIFT IS ABOUT TO HIT THE FAN $ $ $ $ $
i agree with your sentiments and post contents.
this is just step 1,....many more to go. OWCP is on its way with a clear path being cut.
OWCP long and strong !
thanks for posting that article,...important paragraph ===>
Following FDA approval, each new drug must be classified by the DEA. WTHR has learned the DEA will designate Epidiolex as Schedule V, meaning the government believes it represents one of the least dangerous, least harmful and least addictive types of drugs on the market.
and with OWCP's propitiatory extraction technology it will be a superior high quality product !
the OWCP iBox has a huge amount of information on OWCP and it's operations,...just click on Show Intro on the right side of your screen
OWCP Forum iBox
https://investorshub.advfn.com/OWC-Pharmaceutical-Research-Corp-OWCP-16859/
i never stated there was a "correlation".
exactly TappyS. OWCP had some nice buying today. looks like the sells were 108,414 shares and buys were 72,343 shares,..so that interprets to 67% of the sells were bought up,...not earth shattering but the entire market is in correction mode and there is a shift in trends,...with MMJ getting more and more acceptance in the US its just a matter of time when consumers will be seeking state-of-the-art cannabis-based products,...
and OWCP will be there to deliver.
as in,...$ $ $ $ $ $ for OWCP shareholders.
the fact is,... the entire market is down not just OWCP,...and those markets along with OWCP are in a correction phase. that affects all companies, in all sectors stockprice.
ex: AMZN was at $2025,..hit a low of $1887,...GWPH was at $161 a hit a low of $118,...
i could go on and on.
markets correct,...so will OWCP.
and this time with conviction !!!!
you know that,..you're a smart investor.
thanks for your support,...every positive sentiment for OWCP and its success only contributes to further success...
yep,....
THE SHIFTIS ABOUTTO HIT THE FAN. = huge $ $ $ $ $ $ $ $ $ in the PPS
Dr.Hirsch is a brilliant CEO,...a true pioneer in his sector.
LONG & STRONG OWCP !!!!
LAUNCH TIME,...With respect to our timeline going forward, key events till the end of this year include the following:
- Completion of the cannabis cream safety study – Q4 2018
- Initiation of the Oral Disintegrating Tablet safety study – Q4 2018
- Completion of the Nasal Spray animal safety, pharmaco-kinetics and pharmaco-dynamics studies – Q4 2018
THE SHIFT IS ABOUT TO HIT THE FAN
whats good about investing in OWCP is the ability to accumulate at this very inexpensive pps.
i admit i was not one of the early investors and only recently discovered OWCP.
i've been researching and conducting due diligence on OWCP ever since and found every aspect of their strategy to be that of a company with,..
1- propriority products with patents,
2- a disruptive technology approach (extraction method) to their state-of-the-art cannabis based products,
3- able to do that because they are in Israel as opposed to the US,...Israel has more lenient guidelines for research and development,
4- a top notch CEO and BOD and scientists
i've been accumulating shares as the pps moves up or down,...i have a goal of -X- amount of shares.,...my average is now .2452,...and i bought more today.
pretty soon i'll be in the green and the pps haven't even hit $1 mark.
good fortune to you fingers.
you are quite welcome TappyS,...glad it was of assistance to you.
make it a awesome day !
$OWCP,..long and strong,...
THE SHIFT IS ABOUT TO HIT THE FAN $ $ $ $ $ $ $
the OWCP iBox has a huge amount of information on OWCP and it's operations,...just click on Show Intro on the right side of your screen
OWCP Forum iBox
https://investorshub.advfn.com/OWC-Pharmaceutical-Research-Corp-OWCP-16859/
my comprehension of post #149332 ===> this is the only way i know how to answer this intriguing inquiry,...
least we OWCP shareholders forget,...read the message from our CEO ===>
OWCP: Chairman Letter to Shareholders on July 24, 2018
July 24, 2018
I’m simply going to copy/paste the official PR here and bold certain areas that I felt were interesting.
To our Shareholders,
The last period has been an important time for re-assessing our corporate strategy, consolidating our company and strengthening our abilities to execute our strategy. We believe that the strategic re-assessment that we have carried out over the last few months will be critical to our success.
The field in which we operate is increasingly crowded with unproven products. We believe that the companies that will succeed in such a market, will be the ones which have invested their resources in providing validated proof of efficacy and safety for their products. In the past, we have spoken of “market ready” products. This definition related to formulated products which were potentially marketable without the validation that I have eluded to above. We have made the decision that we do not want to compete in this undifferentiated market. Whilst in the short term, this will delay our commercial development, in the long term, this should be strongly value generating for our company and our shareholders.
In order to undertake this positioning, it was important to strengthen our company financially. In May, we announced the closing of the largest funding in the history of our company – a convertible preferred stock offering for US $5 million to an institutional investor. This funding will provide us with the runway to carry out our planned clinical programs. With respect to strengthening our team, we announced the recruitment of Dr. Oron Yacoby Zeevi, formerly CSO at Neuroderm, as our Chief Scientific Officer in February and we are currently planning additional senior personnel additions to increase our capabilities in clinical development and testing.
In December 2017, we announced that we had received a new permit from the Israeli Medical Cannabis Agency (IMCA) to proceed with safety studies for our cannabis soluble tablet delivery system. We subsequently received Institutional Review Board (IRB) approval from the Sourasky Medical Center in Tel Aviv and from the central Israeli Review Board to conduct these studies. In parallel, we announced the completion of the pre-clinical development of our next generation, orally-disintegrating tablet, the subject of the safety studies described above, and the initiation of these studies is now imminent. This tablet is intended to be a replacement for smoking cannabis in chronic pain syndromes. We also announced late in June that we had completed the first stage of the safety study of our cannabis cream. This initial stage comprised the single dosing of healthy volunteers. We are now waiting final volunteer license approval to initiate the second part of this trial, which comprises the twice daily dosing of healthy volunteers for 6 weeks.
With respect to our timeline going forward, key events till the end of this year include the following:
- Completion of the cannabis cream safety study – Q4 2018
- Initiation of the Oral Disintegrating Tablet safety study – Q4 2018
- Completion of the Nasal Spray animal safety, pharmaco-kinetics and pharmaco-dynamics studies – Q4 2018
Whilst we understand that investors are keen to receive news flow, our clinical programs are complex to initiate in that they require multiple levels of approval from different authorities and the studies themselves are time consuming. These clinical programs are however key to our strategy and our positioning as a company dedicated to the pharmaceutical development of cannabis-based products to meet patients’ needs.
On the commercial front, we have continued our business development activities in key future markets for our products. We will announce more specific developments in this area as soon as definitive agreements have been finalized.
The funding that we have obtained provides us with the resources to carry out our research and development programs and to continue our corporate and commercial development. We look forward to updating you on our progress in the coming months.
Yours sincerely,
Dr. Stanley Hirsch,
Chairman of the Board
Link to Original PR at OTCmarkets.com
So, all in all, it was a recap with some additional bonus wording. Is this great news for somebody hoping OWCP would run back to $0.50 by the end of July? Of course not. But, thankfully 99% of the 20+ shareholders I talk to on a monthly basis have all told me they intend to hold long term. They’ve all told me there’s no reason to sell at these levels.
The thing I can’t wait to hear more about is the underlined part of having more specific developments relating to commercial product development agreements. That tells me it’s NOT impossible to expect a Licensing deal in the somewhat shorter term. We’ll see.
Good luck to all. Decide for yourself if you’re going to buy more, hold what you have, or sell some/all. In my opinion, nothing has really changed. This remains an “investment” that requires patience. All investments come with risk.
http://ownthefloat.com/index.php/2018/07/24/owcp-chairman-letter-to-shareholders-on-july-24-2018/
what does any of what you are asking have to do with,....
THE SHIFT IS ABOUT TO HIT THE FAN $$$$$$$$$$$$$$$$$
and OWCP shareholders will reap the benfits.
good night now.
todays comical post,...thanks for the laughs.
you posted the ascertain,...prove it.
prove it.
OWCP was there presenting. end of story. are you gonna doubt they actually were there also.
wow,..just wow !
fantastic article ! thanks for posting it for the forum to inspect.
cannabis is the solution that western medicine has been looking for, they just don't know it yet.
the main aspect of these cannabis products is the full spectrum inclusion of CBD's, CBDa's and other active ingredients. it's the process of extraction that is the importance in the cannabis products. the improper extraction and much of the beneficial aspects of cannabis is gone.
but companies like OWCP knows this.
OWCP is way beyond the bell curve,...
i love the sweet smell of success in the morning.
yes ! yes ! that is exactly how i hear it.
$OWCP - Blah Blah Proof!
Fantasyland Claims against the company
since when is a company asked to be a speaker/presenter at the 2018 Wall Street Conference if it is not genuine a company. WSC is a respected go-to source of pertinent investment companies.
the due diligence and research conducted on OWCP parallels none. by WSC
having OWCP at their conference is proof positive what OWCP is bringing to this new sector.
OWCP is THE real deal,...
get ready for THE SHIFT TO HIT THE FAN
moxa1,...thank you for your kind words. Dr.Hirschs' affiliations are massive. Dr. Hirsch has been in related fields of this business model for years and has accumulated knowledge and as the saying goes,.."It's not what you know but who you know."
Sheba and other Israeli medical facilities are literally around the corner from each other. most of the most contemporary research on cannabis properties and medicinal value is done in Israel because of the lesser restrictions in their country compared to the US. so as a positive consequence what would be restricted here is welcomed as new research with cutting edge approaches.
To date, One World Cannabis has signed research collaboration agreements with a big Academic Medical Center in Israel. Within the framework of these agreements, the company will initiate pre-clinical and clinical studies to explore the effect of several combinations of cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma (a cancer of plasma cells), psoriasis and fibromyalgia.
http://owcpharma.com/research/
this is what is going on in my point of view. cooperative interaction between these medical entities.
OWCP has the goods.
for example,...QCOM had CDMA technology that other cellphone distributors were utilizing,...when QCOM patents came through ALL of those other companies had a choice,...change their technology and operating platform or pay a royalty fee to QCOM to continue using their (QCOM's) platform.
Dr. Hirsch is a very bright man,...i think he takes us this route.
i can be totally incorrect,..this is my WAG.
thanks moxa for all your contributions. they are very appreciated.
yes...they are. i have reason to believe that Dr. Hirsch will be nailing down some specifics with his next communication to OWCP shareholders.
OWCP could have taken the easy route and put a OTC pseudo-based cannabis product (CBD levels in low mg's) just to capture sales.
i'm thinking they, Hirsch and the BOD, are approaching this with all the ammunition they will need once all patents are in place.
HUGE revenue streams can be generated if there are other companies utilizing OWCP's patented process',..which will interpret into a windfall of royalty or licensing fees.
when you're a Hammer,...everything looks like a Nail.
i think we have a motorized Jack-Hammer in our tool kit.
Gary,...its difficult to say exactly b/c of the minimization of information flow from corporate. but i suspect we will be hearing from Dr. Hirsch in the very near future.
but,..something is brewing.
all the studies are cited to be in Q4 of 2018,...
time will tell.
good fortune to you,...
and thank you for your incredible contributions to this OWCP forum.